Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 535 participants.

Also called NCT02864953

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 535 participants (enrolled count) (from the registry)
Sponsor
Remedy Pharmaceuticals, Inc. (from the registry)
Registry
  • NCT NCT02864953
  • EudraCT 2017-004854-41
Other papers using this trial's data
  • Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial The Lancet. Neurology, 2024-12 DOI, PubMed 39577921 PubMed links an erratum for this paper. Erratum: PMID 39706639

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Belgium, Brazil, Canada, China, Croatia, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Japan, Lithuania, Portugal, Russia, South Korea, Spain, Switzerland, Taiwan, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02864953. Randomized; quadruple masking; primary purpose treatment. Start 2018-08-29 (actual); primary completion 2023-08-18 (actual). Results posted on 2024-01-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
Acronym
CHARM
Condition
Brain Edema
Condition
Stroke, Acute
Intervention (Drug)
BIIB093
Intervention (Drug)
Placebo
Lead sponsor
Remedy Pharmaceuticals, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02864953
Content hash
e73c9c1d28c5da525be8f14cabf56ab43fa5a51e6cc60866ce8caaf312716db5